Key facts
- It has raised $470K; the latest was PE Growth/Expansion ($470K) in Aug 2025.
- Status: Acquired/Merged.
- ·Watchlist + deal alerts for InVita Healthcare Technologies
- ·The full record, as it builds
Funding rounds
No funding rounds for InVita Healthcare Technologies are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About InVita Healthcare Technologies
Developer of healthcare software intended for complex medical, forensic, and community care environments. The company's software optimizes supply chains, sample tracking, and visibility across blood and plasma operations, the tissue and implant lifecycle, and environments spanning DNA and forensics, thereby supporting increased compliance and cost control, reduced risk, and improved patient and public safety outcomes.
- Sector
- Healthcare
- HQ
- Baltimore, MD, United States
- Founded
- 2011
- Employees
- 183
- Website
- invitahealth.com/
- Ownership
- Acquired/Merged
InVita Healthcare Technologies doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in InVita Healthcare Technologies shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on InVita Healthcare Technologies in its N-PORT filings yet. We sweep new filings monthly.